Effects of the novel tricyclic quinoxalinedione derivatives, SM-18400 and its analogs, on N-methyl-D-aspartate (NMDA) receptor-mediated synaptic transmission in the isolated neonatal rat spinal cord in vitro

Japanese Journal of Pharmacology

Volumn 76, Issue 3, 1998, Pages 265-270

  Maruoka, Yoshimi ^a   Ohno, Yukihiro ^a   Tanaka, Hiroyasu ^a   Yasuda, Hirokazu ^a   Otani, Ken Ichi ^a   Tamamura, Chika ^a   Nakamura, Mitsutaka ^a  

^a DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

Author keywords

D serine; Glycine binding site; NMDA receptor; SM 18400; Spinal reflex (in vitro)

Indexed keywords

3 AMINO 1 HYDROXY 2 PYRROLIDINONE; 5,7 DICHLORO 1,2,3,4 TETRAHYDRO 4 (3 PHENYLUREIDO) 2 QUINOLINECARBOXYLIC ACID; 5,7 DICHLOROKYNURENIC ACID; 9 CHLORO 5 [4 AMINOMETHYL 2 (CARBOXYMETHOXY)PHENYLCARBAMOYLMETHYL] 6,7 DIHYDRO 1H,5H PYRIDO[1,2,3 DE]QUINOXALINE 2,3 DIONE; DEXTRO SERINE; DIZOCILPINE; DRUG ANALOG; ID 17263; ID 17332; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; QUINOXALINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG POTENCY; MONOSYNAPTIC REFLEX; NEWBORN; NONHUMAN; POLYSYNAPTIC REFLEX; RAT; SPINAL CORD; SYNAPTIC INHIBITION; SYNAPTIC TRANSMISSION;

EID: 0031922349     PISSN: 00215198     EISSN: None     Source Type: Journal    
DOI: 10.1254/jjp.76.265     Document Type: Article

References (26)

1. Lodge D and Johnson KM: Noncompetitive excitatory amino acid receptor antagonists. Trends Pharmacol Sci 11, 81-86 (1990)
2. Meguro H, Mori H, Araki K, Kushiya E, Kutsuwada T, Yamazaki M, Kumanishi T, Arakawa M, Sakimura K and Mishina M: Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs. Nature 357, 70-74 (1992)
3. Choi DW: Glutamate neurotoxicity and diseases of the nervous system. Neuron 1, 623-634 (1988)
4. Meldrum BS: The role of glutamate in epilepsy and other CNS disorders. Neurology 44, Suppl 8, S14-S23 (1994)
5. Muir KW and Lees KR: Clinical experience with excitatory amino acid antagonist drugs. Stroke 26, 503-513 (1995)
6. Koek W and Colpaert FC: Selective blockade of N-methyl-D-aspartate (NMDA)-induced convulsions by NMDA antagonists and putative glycine antagonists: relationship with phencyclidine-like behavioral effects. J Pharmacol Exp Ther 252, 349-357 (1990)
7. Ginski MJ and Witkin JM: Sensitive and rapid behavioral differentiation of N-methyl-D-aspartate receptor antagonists. Psychopharmacology (Berl) 114, 573-582 (1994)
8. Balster RL, Grech DM, Mansbach RS, Li H and Weber E: Behavioral studies of the novel glycine-site NMDA antagonists ACEA 1011 and ACEA 1021 in rats. Soc Neurosci Abstr 19, 472 (1993)
9. Witkin JM, Steele TD and Sharpe LG: Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline. J Pharmacol Exp Ther 280, 46-52 (1997)
10. Nagata R, Tanno N, Kodo T, Ae N, Yamaguchi H, Nishimura T, Antoku F, Tatsuno T, Kato T, Tanaka H, Nakamura M, Ogita K and Yoneda Y: Tricyclic quinoxalinediones: 5,6-dihydro-1H-pyrrolo[1,2,3-de]quinoxaline-2,3-diones and 6,7-dihydro-1H,5H-pyrido[1,2,3-de]quinoxaline-2,3-diones as potent antagonists for the glycine binding site of the NMDA receptor. J Med Chem 37, 3956-3968 (1994)
11. Nagata R, Ae N and Tanno N: Structure-activity relationships of tricyclic quinoxalinediones as potent antagonists for the glycine binding site of the NMDA receptor. Bioorgan Med Chem Lett 5, 1527-1532 (1995)
12. Tanaka H, Yasuda H, Kato T, Maruoka Y, Kawabe A, Kawashima C, Ohtani K and Nakamura M: Neuroprotective and anticonvulsant actions of SM-18400, a novel strychnine-insensitive glycine site antagonist. J Cereb Blood Flow Metab 15, Suppl 1, S431 (1995)
13. Yasuda H, Tanaka H, Ohtani K, Kato T, Maruoka Y, Kawabe A, Kawashima C, Sakamoto H, Tojo S and Nakamura M: Neuroprotective effects of a novel NMDA glycine site antagonist, SM-18400, in the rat model of cerebral ischemia. Soc Neurosci Abstr 21, 996 (1995)
14. Ohno Y and Warnick JE: Presynaptic activation of the spinal serotonergic system in the rat by phencyclidine in vitro. J Pharmacol Exp Ther 250, 177-183 (1989)
15. Ohno Y and Warnick JE: Selective depression of the segmental polysynaptic reflex by phencyclidine and its analogs in the rat in vitro: Interaction with N-methyl-D-aspartate receptors. J Pharmacol Exp Ther 252, 246-252 (1990)
16. Maruoka Y, Ohno Y, Tanaka H, Yasuda H, Otani K, Sakamoto H, Kawabe A, Tamamura C and Nakamura M: Selective depression of the spinal polysynaptic reflex by the NMDA receptor antagonists in an isolated spinal cord in vitro. Gen Pharmacol 29, 645-649 (1997)
17. McNamara D, Smith ECR, Calligaro DO, O'Malley PJ, McQuaid LA and Dingledine R: 5,7-Dichlorokynurenic acid, a potent and selective competitive antagonist of the glycine site on NMDA receptors. Neurosci Lett 120, 17-20 (1990)
18. 3H]L-689,560, and antagonist for the glycine site on the N-methyl-D-aspartate receptor, to rat brain membranes. Mol Pharmacol 41, 923-930 (1992)
19. Tolliver JT and Warnick JE: Aminoglycoside-induced blockade of reflex activity in the isolated spinal cord from neonatal rat. Neurotoxicology 8, 255-268 (1987)
20. Litchfield JT and Wilcoxon F: A simlified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96, 99-113 (1949)
21. Wong EHF, Kemp JA, Priestley T, Knight AR, Woodruff GN and Iversen LL: The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist. Proc Natl Acad Sci USA 83, 7104-7108 (1986)
22. 3H]dichlorokynurenate in rat brain. J Neurochem 60, 634-645 (1993)
23. Pole P: 2-Amino-7-phosphonoheptanoic acid depresses γ-motoneurons and polysynaptic reflexes in the cat spinal cord. Eur J Pharmacol 117, 387-389 (1985)
24. Jahr CE and Yoshioka K: Ia Afferent excitation of motoneurons in the in vitro new-born rat spinal cord is selectively antagonized by kynurenate. J Physiol (Lond) 370, 515-530 (1986)
25. Turski L, Bressler K, Klockgether T and Stephens DN: Differential effects of the excitatory amino acid antagonists, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 3-((±)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP), on spinal reflex activity in mice. Neurosci Lett 113, 66-71 (1990)
26. Block F and Schwarz M: The depressant effect of GYKI 52466 on spinal reflex transmission in rats is mediated via non-NMDA and benzodiazepine receptors. Eur J Pharmacol 256, 149-153 (1994)